Latest Updates

The AmerisourceBergen State Government Affairs team successfully opposed tax legislation in Washington and Hawaii which would have significantly burdened providers and patients and negatively impacted healthcare supply chain participants.

Jenni Zilka, President of Good Neighbor Pharmacy, recently had a letter to the editor published in the Washington Post, urging that pharmacists be provided the opportunity and means to successful carry out the program. Jenni’s letter to the editor calls for the FDA to amend the EUA for COVID-19 oral antivirals to give pharmacists the ability to prescribe and advocates for a permanent reimbursement infrastructure for clinical services provided by pharmacists in Medicare.

AmerisourceBergen continues to actively advocate for independent pharmacies regarding CMS’ 2023 proposed rule that affects patient copay outlays at the pharmacy counter.

U.S. Senate and House pharmacy champions are leading bipartisan efforts to voice support for CMS’ proposed action on pharmacy DIR fees. NCPA has created an easy way for pharmacy owners and staff to contact their U.S. Senators and Representatives and urge them to sign on to their respective letters.

Government bought the pills, but dispensing fees were left up to private firms, with many pharmacies out of pocket filling the prescriptions.